0001493152-18-009665.txt : 20180703 0001493152-18-009665.hdr.sgml : 20180703 20180703153404 ACCESSION NUMBER: 0001493152-18-009665 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180614 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anderson David Evander CENTRAL INDEX KEY: 0001616018 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37769 FILM NUMBER: 18936855 MAIL ADDRESS: STREET 1: C/O VBI VACCINES INC. STREET 2: 222 THIRD STREET, STE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VBI Vaccines Inc/BC CENTRAL INDEX KEY: 0000764195 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-830-3031 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: SciVac Therapeutics Inc. DATE OF NAME CHANGE: 20150717 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD. DATE OF NAME CHANGE: 20100910 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD DATE OF NAME CHANGE: 19850305 4/A 1 ownership.xml X0306 4/A 2018-06-14 2018-06-18 0 0000764195 VBI Vaccines Inc/BC VBIV 0001616018 Anderson David Evander C/O VBI VACCINES INC., 222 THIRD STREET, STE 2241 CAMBRIDGE, MA 02142 0 1 0 0 Chief Scientific Officer Common Shares, no par value per share 2018-06-14 4 F 0 9281 3.76 D 101334 D On June 18, 2018, the reporting person filed a Form 4 which inadvertently reported that 9,306 common shares were withheld to satisfy the tax liability in connection with vesting of 21,875 restricted stock units and that the reporting person beneficially owns 101,309 shares following the reported transaction. In fact, as reported in this amendment, 9,281 common shares were withheld to satisfy the tax liability in connection with the vesting of restricted stock units, and the reporting person beneficially owns 101,334 common shares following the reported transaction. /s/ David E. Anderson 2018-07-03